🇺🇸 FDA
Patent

US 9642909

Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants

granted A61KA61K2039/522A61K2039/54

Quick answer

US patent 9642909 (Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants) held by Sanaria Inc. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sanaria Inc.
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/522, A61K2039/54, A61K2039/55511, A61K39/015